https://www.selleckchem.com/products/AC-220.html
ials.BACKGROUND To meet clinical needs, fluorescence-guided surgery has emerged as a new technique that guides surgeons in the resection of cancerous tissue by highlighting tumour lesions during surgery. We aimed to evaluate the novel ovarian cancer-specific antibody fluorescent probe COC183B2-800 (COC183B2 conjugated with IRDye800CW) in tumour-specific imaging to determine if it can help surgeons remove malignant lesions under fluorescence guidance. METHODS The expression of OC183B2 antigen in epithelial ovarian cancer (EOC) tissues and
Aimer
Commentaire
Partagez
